门冬氨酸转氨酶、丙氨酸转氨酶与γ谷氨酰基转移酶在肝硬化患者中的变化及临床意义

Abstract
Figure/Table
References (18)
Related Citation (15)

Download: PDF (470 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the changes and clinical significance of aspartate aminotransferase (AST), alanine aminotransferase (ALT) and γ-glutamyl transferase (γ-GT) in patients with cirrhosis. Methods A total of 40 patients with liver cirrhosis diagnosed in the Department of Laboratory, the Third Affiliated Hospital of Sun Yat-Sen University Yuedong Hospital from January 2019 to December 2020 were selected as the research objects, and 20 healthy people who underwent physical examination in the Third Affiliated Hospital of Sun Yat-Sen University Yuedong Hospital in the same period were selected as the control group. The AST, ALT and γ-GT tests were performed respectively. AST,ALT, γ-GT, cholinesterase (CHE), total protein (TP), albumin (ALB), albumin/globulin (A/G), alpha fetoprotein (AFP),glutamate dehydrogenase (GLDH), adenosine deaminase (ADA), a-algae glycosidase (AFU), J3-N-acetylglucosidase(NAG) and leucine aminopeptidase (LAP) levels were cmpared between the two groups. Results The levels of AST, ALT and γ-GT in experimental group were higher than those in control group, and the differences were statistically significant (P<0.05). The levels of AFP, GLDH, ADA, AFU, NAG and LAP in experimental group were higher than those in control group, and the differences were statistically significant (P<0.05). The levels of ALB, TP, CHE and A/G in experimental group were lower than those in control group, and the differences were statistically significant (P<0.05).Conclusion AST, ALT and γ-GT is a sensitive index for the examination and diagnosis of liver cirrhosis, which can provide basis for disease diagnosis.

Key words： Liver cirrhosis Liver function Biochemical test Laboratory index

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LI Lingfeng
	WEI Huiping
	LIU Guirong
	XIE Yanfang

Cite this article:

LI Lingfeng,WEI Huiping,LIU Guirong, et al. Changes and clinical significance of aspartate aminotransferase, alanine aminotransferase and γ-glutamyl transferase in patients with cirrhosis[J]. 中国当代医药, 2022, 29(6): 110-113.

URL:

https://www.dangdaiyiyao.com/EN/ OR https://www.dangdaiyiyao.com/EN/Y2022/V29/I6/110

[1]	傅求真，白玉蓉，寇丹，等.脂肪肝患者ALT、AST、γ-GT 水平及意义[J].中华保健医学杂志，2019，21（5）：454-455.
[2]	郝一鸣，王士琪，冯全新，等.脂肪肝诊断联合APACHE-Ⅱ评分提高预测重症急性胰腺炎的能力[J].中华普通外科杂志，2016，31（1）：23-26.
[3]	孔庆飞，班立芳，冯煦，等.生化指标检验在肝硬化诊断中的价值[J].菏泽医学专科学校学报，2018，30（3）：1-3，17.
[4]	李成富，罗安成，张海业，等.生化检验在肝硬化诊断中的临床价值[J].深圳中西医结合杂志，2018，28（15）：84-85.
[5]	韦丽梅.四项生化指标检验在肝硬化和病毒性肝炎中的应用价值分析[J].吉林医学，2019，40（2）：361-362.
[6]	于丽娟，于箭，于丽云.生化检验指标在肝硬化疾病诊断中的作用[J].中国现代药物应用，2019，13（21）：39-40.
[7]	吴振兴.多项生化指标联合检测在不同肝脏疾病诊断与治疗中的意义[J].齐齐哈尔医学院学报，2017，38（12）：1414-1416.
[8]	王爱成.生化检验项目用于肝硬化疾病诊断中的临床价值研究[J].中国实用医药，2019，14（14）：51-52.
[9]	陈红霞.生化指标检验在肝硬化疾病诊断中的价值[J].中外医疗，2018，37（10）：187-189.
[10]	黄伟，张欣欣.非酒精性脂肪性肝病相关肝癌发病机制的研究进展[J].中华肝脏病杂志，2017，25（2）：157-160.
[11]	陈东风，孙文静，刘凯军，等.非酒精性脂肪性肝病相关性肝癌的流行病学现状与发病机制[J].中华肝脏病杂志，2017，25（2）：111-114.
[12]	邓中波，刘付宝.肝脏脂肪变性对肝癌患者肝癌切除根治术安全性的影响[J].山东医药，2017，57（13）：72-74.
[13]	梁健夫，张昌森，谢晓婷.生化检验中CHE、ALT 及AST在肝硬化疾病诊断中的应用价值[J].中国医药科学，2020，10（11）：126-128.
[14]	黄水荣.生化检验诊断肝硬化疾病患者的作用分析[J].当代医学，2020，26（6）：136-137.
[15]	张春雨.凝血酶原时间和血小板检验对诊断肝硬化疾病的临床应用效果[J].当代医学，2021，27（23）：31-33.
[16]	何娅娣，吴振权，侯国良.血浆环状RNA_0002867 对HBV相关性肝癌诊断价值的初步研究[J].新医学，2021，52（8）：572-575.
[17]	齐小健.肝炎肝硬化患者肝功能的检测价值[J].中国现代医生，2021，59（5）：104-106.
[18]	梁健夫，张昌森，谢晓婷.生化检验中CHE、ALT 及AST 在肝硬化疾病诊断中的应用价值[J].中国医药科学，2020，10（11）：126-128.